Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Arnold

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedicines|July 27, 2022
Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot UlcerRacha El Hage, Uwe Knippschild, Tobias Arnold, et al.
Analytical Chemistry|January 31, 2018
Hand-Held Photometer for Instant On-Spot Quantification of Nucleic Acids, Proteins, and CellsShi-Hao Li, Abhinav Jain, Timo Tscharntke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
Drug survival rates and reasons for drug discontinuation in psoriasisTobias Arnold, Marthe-Lisa Schaarschmidt, Raphael Herr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
"Drug-Survival"-Raten und Gründe für den Abbruch von Systemtherapien bei PsoriasisTobias Arnold, Marthe-Lisa Schaarschmidt, Raphael Herr, et al.
Emerging Infectious Diseases|June 22, 2022
Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, GermanyJanina Trauth, Thomas Discher, Moritz Fritzenwanker, et al.
Molecular Therapy Oncolytics|October 17, 2017
Targeting an Oncolytic Influenza A Virus to Tumor Tissue by ElastaseIrina Kuznetsova, Tobias Arnold, Thomas Aschacher, et al.
European Journal of Clinical Investigation|February 16, 2013
Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancerTobias Arnold, Anna Michlmayr, Suzann Baumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 18, 2019
Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter studyChristian Kromer, Dagmar Wilsmann-Theis, Sascha Gerdes, et al.
Cancer Medicine|July 27, 2016
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapyRuth Exner, Monika Sachet, Tobias Arnold, et al.
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicines|July 27, 2022
Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot UlcerRacha El Hage, Uwe Knippschild, Tobias Arnold, et al.
Analytical Chemistry|January 31, 2018
Hand-Held Photometer for Instant On-Spot Quantification of Nucleic Acids, Proteins, and CellsShi-Hao Li, Abhinav Jain, Timo Tscharntke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
Drug survival rates and reasons for drug discontinuation in psoriasisTobias Arnold, Marthe-Lisa Schaarschmidt, Raphael Herr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
"Drug-Survival"-Raten und Gründe für den Abbruch von Systemtherapien bei PsoriasisTobias Arnold, Marthe-Lisa Schaarschmidt, Raphael Herr, et al.
Emerging Infectious Diseases|June 22, 2022
Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, GermanyJanina Trauth, Thomas Discher, Moritz Fritzenwanker, et al.
Molecular Therapy Oncolytics|October 17, 2017
Targeting an Oncolytic Influenza A Virus to Tumor Tissue by ElastaseIrina Kuznetsova, Tobias Arnold, Thomas Aschacher, et al.
European Journal of Clinical Investigation|February 16, 2013
Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancerTobias Arnold, Anna Michlmayr, Suzann Baumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 18, 2019
Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter studyChristian Kromer, Dagmar Wilsmann-Theis, Sascha Gerdes, et al.
Cancer Medicine|July 27, 2016
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapyRuth Exner, Monika Sachet, Tobias Arnold, et al.
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Pageof 1